Zobrazeno 1 - 8
of 8
pro vyhledávání: '"I. A. Shafieva"'
Autor:
N. K. Ossina, L. T. Volova, P. A. Lebedev, I. A. Shafieva, E. I. Pugachev, S. A. Goncharenko, S. I. Kuznetsov, O. A. Gusyakova, G. N. Svetlova
Publikováno v:
Медицинская иммунология, Vol 26, Iss 5, Pp 897-904 (2024)
Currently, gouty arthritis is considered as a polygenic multifactorial autoinflammatory disease caused by activation of the NOD (nucleotide-binding domain) -like protein receptor 3 inflammasome NLRP3. The two cytokines IL-1β and IL-18 are considered
Externí odkaz:
https://doaj.org/article/3b0c34c471cf4bb68546721cdedfce49
Autor:
A. M. Lila, I. Z. Gaydukova, O. N. Anoshenkova, I. G. Bannikova, I. B. Vinogradova, M. L. Goldman, S. Yu. Davidian, L. P. Evstigneeva, O. E. Epifanova, E. V. Zemerova, A. I. Zagrebneva, L. V. Ivanova, A. K. Karibova, I. V. Menshikova, O. N. Mironenko, M. P. Mikhailova, N. E. Nikulenkova, I. M. Patrikeeva, T. V. Plaksina, G. R. Savvina, R. R. Samigullina, L. E. Sarantseva, J. V. Usacheva, O. P. Ukhanova, G. F. Fatkhullina, A. L. Chudinov, I. A. Shafieva, S. P. Yakupova
Publikováno v:
Современная ревматология, Vol 18, Iss 3, Pp 32-43 (2024)
The efficacy and safety of levilimab (LVL) in patients with active rheumatoid arthritis (RA) has been confirmed in controlled clinical trials. This article presents the results of a preliminary analysis of a non-interventional observational study of
Externí odkaz:
https://doaj.org/article/4031788a32de403ebea6e82d4f01065d
Publikováno v:
Медицинский совет, Vol 0, Iss 11, Pp 96-101 (2022)
Introduction. From the perspective of evidence-based medicine, bisphosphonates (BP) represented by several drugs with various routes of administration and dosing regimens have been recognized as the gold standard for the treatment of osteoporosis (OP
Externí odkaz:
https://doaj.org/article/dfd405b472c14d538a7bb0ed7388f97e
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 241-246 (2021)
Introduction. The use of bisphosphonates is associated with some risk of side effects. Gastrointestinal tract complications are particularly important in clinical practice, as they constitute the main reason for refusing bisphosphonate therapy.Object
Externí odkaz:
https://doaj.org/article/68ac33bfd96549fda44f5cf3d17f1714
Publikováno v:
Медицинский совет, Vol 0, Iss 3, Pp 139-142 (2020)
Introduction. To evaluate the effect of hormone replacement therapy on periodontal treatment outcomes complex, bone mineral density and articular syndrome in a group of postmenopausal women.Materials and methods. We carried out an exploration of 32 p
Externí odkaz:
https://doaj.org/article/1ba245f1d4c342448f91d65c0bd082e2
Autor:
A. E. Karateev, E. Yu. Pogozheva, V. N. Amirjanova, E. S. Filatova, A. M. Lila, V. I. Mazurov, R. R. Samigullina, A. M. Dadalova, A. Yu. Dyo, D. S. Chakieva, A. A. Baranov, N. A. Lapkina, E. N. Koltsova, N. A. Kiryukhina, I. N. Shchendrigin, T. G. Rasevich, A. F. Davydova, I. V. Semizarova, I. A. Shafieva, I. B. Bashkova, D. A. Bobrikova, D. A. Murtazalieva, I. N. Kushnir, E. V. Kalinina, T. S. Salnikova, I. M. Marusenko, O. V. Semagina, I. B. Vinogradova, D. G. Krechikova, M. Yu. Semchenkova, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 4 (2021)
The JAK inhibitor tofacitinib (TOFA) blocks the intracellular signaling pathway that activates the synthesis of cytokines and mediators involved in the development of pain and central sensitization (CS), which determines the rapid analgesic effect. H
Externí odkaz:
https://doaj.org/article/f878a9466c984864885b3baf4937c75e
Autor:
SV BULGAKOVA, I A ShAFIEVA
Publikováno v:
Остеопороз и остеопатии, Vol 19, Iss 2 (2016)
Низкотравматичные переломы проксимального отдела бедренной кости (ПОБК) и дистального отдела предплечья (ДОП) у лиц старше 50 лет - часто
Externí odkaz:
https://doaj.org/article/9f680e2eedbb410987726fc73bd8c321
Autor:
I A ShAFIEVA, S V BULGAKOVA
Publikováno v:
Остеопороз и остеопатии, Vol 19, Iss 2, Pp 82-82 (2016)
Золедроновая кислота - препарат антирезорбтивного действия для лечения системного остеопороза (ОП). Цель: изучить переносимость препар
Externí odkaz:
https://doaj.org/article/1be4635a7ccf49bbbbd6d36601c194ad